Australia's New Vaping Restrictions Under Scrutiny

In a surprising move, Australia's Health Minister Mark Butler recently announced additional restrictions on vaping products, despite extensive peer-reviewed studies and advice from smoking cessation experts regarding the effectiveness of tobacco harm reduction strategies. This decision has raised concerns among forty-two tobacco control and addiction experts from Australia and New Zealand, prompting them to write a letter urging the Minister to reconsider. Renowned experts, such as Dr. Colin Mendelsohn and Dr. Wayne Wodak, emphasized that these further restrictions would only contribute to a thriving black market, endangering minors with potentially unsafe products. Additionally, adult smokers would face even greater challenges in accessing safer alternatives, which are already difficult to obtain through legal channels.

Experts Highlight the Consequences of Stricter Vape Regulations

Private correspondence among members of the Australian Nicotine Advisory Council (ANACAD), obtained under freedom of information, has revealed their alarm at the consideration of harsher vape restrictions. The experts expressed their concern that the Minister has been exclusively listening to internal advisers and anti-vaping health organizations while disregarding opposing views. Dr. Mendelsohn, in an interview with Vaping Post, acknowledged that it would be difficult to ignore the expert opinions outlined in the correspondence. He further discussed the council's awareness that imposing additional restrictions would exacerbate the situation and stressed the importance of sensible regulation informed by scientific evidence. The council members also rejected the controversial "Gateway Theory," which has been a driving force behind many vape restrictions, arguing that policy decisions should rely on scientific facts.

Furthermore, the emails disclosed that the council members do not believe that vapers should be required to consult with a doctor. Instead, they firmly support the effectiveness of tobacco harm reduction models. Dr. Mendelsohn elaborated on these matters in his blog post, emphasizing that the revealed emails contain substantial evidence that cannot be easily dismissed. He described the correspondence as "dynamite," highlighting its potential impact.

Controversial Partnership: Australian Pharmacies and PMI

In a separate development, several Australian pharmacies have entered into a controversial supply agreement with tobacco giant Philip Morris International (PMI), enabling them to sell VEEV nicotine pods and devices with an 80% margin. Interestingly, PMI openly opposes the government's prescription vaping model while actively lobbying for a consumer model. This agreement between PMI and the pharmacies raises eyebrows as it appears to be an attempt by the tobacco company to disrupt competition and undermine the prescription access model.

To benefit from this deal, pharmacies must sign a supply agreement directly with PMI and comply with specific conditions. These conditions include selling a pack of two VEEV nicotine pods for no more than $14.90 and devices for no more than $19.90. Notably, these prices are cheaper than what wholesalers typically offer, considering that comparable pod products usually retail around $24.99. It's worth mentioning that the marketing material for this offer only briefly mentions PMI in fine print at the bottom of the document.

Simon Chapman, an emeritus professor of public health and tobacco control at the University of Sydney, believes that PMI is strategically disrupting the prescription access model to gain an advantage over its competitors. He points out that PMI's vocal opposition to the prescription model and advocacy for a consumer-driven approach aligns with their long-term agenda.

In response to this controversial partnership, Vaping Post sought the opinion of Dr. Mendelsohn. While acknowledging the prevalent negative sentiment towards tobacco companies within the field, he prioritizes the goal of helping smokers quit as soon as possible, regardless of the products they use. Dr. Mendelsohn believes that smokers should have a range of choices, and all products, including those from the tobacco industry, should compete in the marketplace. He further states that encouraging the tobacco industry to produce safer nicotine alternatives is preferable to the production of deadly combustible cigarettes.


Australia's decision to tighten restrictions on vaping products, despite advice from experts and extensive scientific evidence, has generated significant concern among tobacco control and addiction experts. The imposed restrictions are likely to contribute to the growth of a thriving black market, exposing minors to potentially unsafe products. Furthermore, adult smokers will face even greater difficulties in accessing safer alternatives that are already challenging to obtain legally. The private correspondence of ANACAD members, along with the controversial agreement between Australian pharmacies and PMI, sheds light on the need for sensible regulation based on scientific evidence and the importance of providing smokers with a variety of options to quit smoking.


  1. Are tobacco harm reduction strategies effective? Yes, numerous peer-reviewed studies and experts have demonstrated the effectiveness of tobacco harm reduction strategies in helping smokers quit.

  2. Why are further restrictions on vaping products concerning? Further restrictions on vaping products can lead to a thriving black market, making potentially unsafe products accessible to minors and making it harder for adult smokers to access safer alternatives.

  3. What is the "Gateway Theory"? The "Gateway Theory" suggests that using e-cigarettes or vaping products may lead to smoking traditional cigarettes. However, many experts, including those from the ANACAD, do not believe in this theory and argue for policy decisions based on scientific evidence.

  4. Why is the deal between Australian pharmacies and PMI controversial? The deal between Australian pharmacies and PMI is controversial because it appears to disrupt the competition and undermine the prescription access model, which PMI openly opposes.

  5. What is the opinion of experts on the partnership with PMI? While there is general resentment towards tobacco companies, experts like Dr. Mendelsohn prioritize smokers quitting as soon as possible. They believe that smokers should have choices, and encouraging tobacco companies to produce safer nicotine alternatives can be a positive step forward in harm reduction efforts.

Posted in Business blogs on July 18 at 02:56 AM

Comments (1)

No login